Abbvie IncABBV
Price$283.40Intrinsic value$195.2031% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $64.4B+14.3% YoYTTM through 30 Jun 2026
Net Income $6.3B+47.5% YoYTTM through 30 Jun 2026
Free Cash Flow $18.2BTTM through 30 Jun 2026

Margins

Current
Gross Margin71.9%
EBITDA Margin38.6%
Operating Margin26.6%
Net Margin9.8%

Returns

N/A (negative equity)ROE
2.7%ROA
12.1%ROIC

Balance Sheet Health

Debt / EquityN/A (negative equity)
Current Ratio0.80x
Net Debt$63.5B
Cash & Equivalents$6.6B

Quality Metrics

Altman Z-Score2.63
Piotroski F-Score7 / 9
FCF Margin28.3%
Rule of 4033.3
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $61.2B
Diluted EPS$3.54TTM
'19'20'21'22'23'24'25
FY2025: $2.36

Dividend

$5.19Per share, FY20263.11%Yield0.0%5-yr growth

Capital Allocation

Capex Intensity2.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.